Brouxhon S - Search Results

1

Deletion of prostaglandin E2 EP2 receptor protects against ultraviolet-induced carcinogenesis, but increases tumor aggressiveness.

Brouxhon S, Konger RL, VanBuskirk J, Sheu TJ, Ryan J, Erdle B, Almudevar A, Breyer RM, Scott G, Pentland AP. Brouxhon S, et al. J Invest Dermatol. 2007 Feb;127(2):439-46. doi: 10.1038/sj.jid.5700547. Epub 2006 Sep 14. J Invest Dermatol. 2007. PMID: 16977324 Free article.

2

Cyclooxygenase-1 deletion enhances apoptosis but does not protect against ultraviolet light-induced tumors.

Pentland AP, Scott G, VanBuskirk J, Tanck C, LaRossa G, Brouxhon S. Pentland AP, et al. Among authors: brouxhon s. Cancer Res. 2004 Aug 15;64(16):5587-91. doi: 10.1158/0008-5472.CAN-04-1045. Cancer Res. 2004. PMID: 15313895

3

Sequential down-regulation of E-cadherin with squamous cell carcinoma progression: loss of E-cadherin via a prostaglandin E2-EP2 dependent posttranslational mechanism.

Brouxhon S, Kyrkanides S, O'Banion MK, Johnson R, Pearce DA, Centola GM, Miller JN, McGrath KH, Erdle B, Scott G, Schneider S, VanBuskirk J, Pentland AP. Brouxhon S, et al. Cancer Res. 2007 Aug 15;67(16):7654-64. doi: 10.1158/0008-5472.CAN-06-4415. Cancer Res. 2007. PMID: 17699770

4

The EP3 receptor stimulates ceramide and diacylglycerol release and inhibits growth of primary keratinocytes.

Konger RL, Brouxhon S, Partillo S, VanBuskirk J, Pentland AP. Konger RL, et al. Among authors: brouxhon s. Exp Dermatol. 2005 Dec;14(12):914-22. doi: 10.1111/j.1600-0625.2005.00381.x. Exp Dermatol. 2005. PMID: 16274459

5

Effects of continuous-wave (670-nm) red light on wound healing.

Erdle BJ, Brouxhon S, Kaplan M, Vanbuskirk J, Pentland AP. Erdle BJ, et al. Among authors: brouxhon s. Dermatol Surg. 2008 Mar;34(3):320-5. doi: 10.1111/j.1524-4725.2007.34065.x. Epub 2007 Dec 20. Dermatol Surg. 2008. PMID: 18177400

6

Soluble E-cadherin: a critical oncogene modulating receptor tyrosine kinases, MAPK and PI3K/Akt/mTOR signaling.

Brouxhon SM, Kyrkanides S, Teng X, Athar M, Ghazizadeh S, Simon M, O'Banion MK, Ma L. Brouxhon SM, et al. Oncogene. 2014 Jan 9;33(2):225-35. doi: 10.1038/onc.2012.563. Epub 2013 Jan 14. Oncogene. 2014. PMID: 23318419 Free PMC article.

7

Abnormal PGE(2) regulation of monocyte TNF-alpha levels in trauma patients parallels development of a more macrophage-like phenotype.

Laudanski K, De A, Brouxhon S, Kyrkanides S, Miller-Graziano C. Laudanski K, et al. Among authors: brouxhon s. Shock. 2004 Sep;22(3):204-12. doi: 10.1097/01.shk.0000135289.62159.ad. Shock. 2004. PMID: 15316388

8

Ectodomain-specific E-cadherin antibody suppresses skin SCC growth and reduces tumor grade: a multitargeted therapy modulating RTKs and the PTEN-p53-MDM2 axis.

Brouxhon SM, Kyrkanides S, Raja V, Silberfeld A, Teng X, Trochesset D, Cohen J, Ma L. Brouxhon SM, et al. Mol Cancer Ther. 2014 Jul;13(7):1791-802. doi: 10.1158/1535-7163.MCT-13-0971. Epub 2014 Apr 18. Mol Cancer Ther. 2014. PMID: 24748654

9

Intraperitoneal inoculation of Sandhoff mouse neonates with an HIV-1 based lentiviral vector exacerbates the attendant neuroinflammation and disease phenotype.

Kyrkanides S, Miller JN, Tallents RH, Brouxhon SM, Centola GM, Olschowka JA. Kyrkanides S, et al. Among authors: brouxhon sm. J Neuroimmunol. 2007 Aug;188(1-2):39-47. doi: 10.1016/j.jneuroim.2007.05.010. Epub 2007 Jun 18. J Neuroimmunol. 2007. PMID: 17572511

10

Spinal interleukin-1beta in a mouse model of arthritis and joint pain.

Fiorentino PM, Tallents RH, Miller JN, Brouxhon SM, O'Banion MK, Puzas JE, Kyrkanides S. Fiorentino PM, et al. Among authors: brouxhon sm. Arthritis Rheum. 2008 Oct;58(10):3100-9. doi: 10.1002/art.23866. Arthritis Rheum. 2008. PMID: 18821694 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

30 results

Search Page